Cystic fibrosis: An update for the otolaryngologist

Otolaryngology - Head and Neck Surgery

Volumn 120, Issue 4, 1999, Pages 502-506

  Halvorson, David J ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; DORNASE ALFA; URIDINE TRIPHOSPHATE;

AUTOSOMAL RECESSIVE DISORDER; CYSTIC FIBROSIS; HUMAN; LUNG TRANSPLANTATION; MEDICAL SPECIALIST; OTORHINOLARYNGOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

EID: 0032895517     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1053/hn.1999.v120.a92379     Document Type: Article

References (50)

1. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis J Pediatr 1994;124:177-92.
2. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis (state of the art). Am Rev Respir Dis 1976;113:833-78.
3. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
4. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-9.
5. Rommens J, Iannuzzi M, Kerem B-S, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
6. Riordan J, Rommens J, Kerem B-S, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
7. Kerem B-S, Rommens J, Buchanan J, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
8. Patient registry 1993 annual data report. Bethesda (MD): Cystic Fibrosis Foundation; 1994.
9. Rosenstein BJ, Langbaum TS. Diagnosis. In: Taussig LM, editor. Cystic fibrosis. New York: Thieme, 1984. p. 85-114.
10. Neely JG, Harrison GM, Jerger JF, et al. The otolaryngologic aspects of cystic fibrosis. Trans Am Acad Ophthalmol Otolaryngol 1972;76:313-24.
11. Cepero R, Smith RH, Catlin FI, et al. Cystic fibrosis - an otolaryngologic perspective. Otolaryngol Head Neck Surg 1987;97: 356-60.
12. Leiberman A, Cole P, Corey M, et al. Otolaryngological and rhinomanometric findings in cystic fibrosis. Am J Rhinol 1991;5: 61-5.
13. Magid SL, Smith CC, Dolowitz DA. Nasal mucosa in pancreatic cystic fibrosis. Arch Otolaryngol Head Neck Surg 1967;86:106-10.
14. Rulon JT, Logan GB. Nasal polyps and cystic fibrosis of the pancreas. Arch Otolaryngol Head Neck Surg 1963;78:192-9.
15. Stern RC, Boat TF, Wood RE, et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982;136:1067-70.
16. Brihaye P, Clement PAR, Dab I, et al. Pathological changes of the lateral nasal wall in patients with cystic fibrosis (mucoviscidoss). Int J Pediatr Otorhinolaryngol 1994;28:141-7.
17. Oppenheimer EH, Rosenstein BJ. Differential pathology of nasal polypsin cystic fibrosis atopy. Lab Invest 1979;40:455-9.
18. King V. Upper respiratory disease, sinusitis and polyposis. Clin Rev Allergy 1991;9:143-58.
19. Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 1992;90:547-52.
20. Ledesma-Medina J, Ozman MZ, Girdany BR. Abnormal paranasal sinuses in patients with cystic fibrosis of the pancreas. Pediatr Radiol 1980;9:61-4.
21. April MM, Zinreich SJ, Baroody FM, et al. Coronal CT scan abnormalities in children with chronic sinusitis. Laryngoscope 1993;103:985-90.
22. Cuyler JP, Monaghan AJ. Cystic fibrosis and sinusitis. J Otolaryngol 1989;18:173-5.
23. Halvorson DJ, Dupree JR, Porubsky ES. Management of chronic sinusitis in the adult cystic fibrosis patient. Ann Otol Rhinol Laryngol 1998;107:946-52.
24. Duplechain JK, White JA, Miller RH. Pediatricsinusitis. the role of endoscopic sinus surgery in cystic fibrosis and other forms of sinonasal disease. Arch Otolaryngol 1991;117:422-6.
25. Parsons DS. Sinusitis and cystic fibrosis. In: Lusk RP, editor. Pediatric sinusitis. New York: Raven Press; 1992. p. 65-70.
26. Cuyler JP. Follow up of endoscopic sinus surgery on children with cystic fibrosis. Arch Otolaryngol 1992;118:505-6.
27. Crockett DM, McGill TJ, Healy GB, et al. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann Otol Rhinol Laryngol 1987;96:367-2.
28. Jones JW, Parsons DP, Cuyler JP. The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol 1993;28:25-32.
29. Davidson TM, Murphy C, Mitchell M, et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995;105:354-8.
30. Nishioka GJ, Barbero GJ, Konig P, et al. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg 1995;113: 440-5.
31. Umetsu DT, Moss RB, King VV, et al. Sinus disease in patients with severe cystic fibrosis relation to pulmonary exacerbation. Lancet 1990;335:1078-80.
32. Madonna D, Isaacson G, Rosenfeld RM, et al. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope 1997;107:328-31.
33. Kulczycki LL, Butler JS, McCord-Dickman D, et al. The hearing of patients with cystic fibrosis. Arch Otolaryngol 1970;92:54-9.
34. Forcucci RA, Stark EW. Hearing loss, speech-language, and cystic fibrosis. Arch Otolaryngol 1972;96:361-4.
35. Jerger JF, Neely JG. Audiometric testing. Arch Otolaryngol Head Neck Surg 1971;93:111-2.
36. Bak-Pedersen K, Kildegaard LP. Inflammatory middle ear diseases in patients with cystic fibrosis. Acta Otolaryngol 1979;360 (Suppl):130-40.
37. Cipolli M, Canciani M, Cavazzani M, et al. Ear disease is not a common complication in cystic fibrosis. Eur J Pediatr 1993;152: 265-6.
38. Haddad J, Gonzales C, Kurland G, et al. Ear disease in children with cystic fibrosis. Arch Otolaryngol Head Neck Surg 1994; 120:491-3.
39. Ozcelik T, Ozgirgin N, Ozcelik U, et al. Auditory nerve-brainstem responses in cystic fibrosis patients Int J Pediatr Otorhinolaryngol 1996;35:165-9.
40. Bak-Pedersen K, Larsen PK. Inflammatory middle ear diseases in patients with cystic fibrosis. Acta Otolaryngol Suppl (Stockh) 1979;360:138-40.
41. Kulczycki LL, Herer GR, Butler JS. Cystic fibrosis and hearing: integrity of the upper respiratory tract as related to hearing sensitivity. Clin Pediatr 1970;9:390-402.
42. Colton HR. Airway inflammation in cystic fibrosis [comment]. N Engl J Med 1995;332:886-7.
43. Frist WH, Campbell PW, Fiel SB, et al. Cystic fibrosis treated with heart-lung transplantation: North American results. Transplant Proc 1991;23:1205-6.
44. Fradet G, Smyth RL, Scott JP, et al. Cystic fibrosis: a new challenge for cardiothoracic surgery. Eur J Cardiothorac Surg 1990; 4:136-40.
45. Starnes VA, Lewiston N, Theodore J, et al. Cystic fibrosis target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg 1992;103:1008-14.
46. Lewiston N, King V, Umetsu D, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991;23:1207-8.
47. Shah PL, Hodsen ME. New treatment strategies in cystic fibrosis. Mondali Arch Chest Dis 1996;51:125-9.
48. Mylett J, Johnson L, Knowles M. Alternative therapies for cystic fibrosis. Semin Respir Crit Care Med 1994;15:426-33.
49. Bennett WD, Olivier KN, Zeman KL, et al. Acute effect of aerosolized uridine 5′-triphosphate (UTP) amiloride on mucociliary clearance in cystic fibrosis (CF) [abstract]. Am J Respir Crit Care Med 1994;149:A670.
50. Wilson JM. Prospects for gene therapy. In: Highlights. Bethesda (MD): Cystic Fibrosis Foundation; 1995. p. 20-2.